BrainSightAI is using latest technological advances in healthcare to improve our understanding of brain functions, neural systems and environmental triggers

How does it work?

Neuropsychiatric disorders are the third leading cause of global disease burden with an estimated impact of 16.3 Trillion USD*

 

* Source: National Institute of Mental Health and data from WHO

Therapist

AI today has the potential to enable a more holistic view of the patient's brain for significantly better outcomes for patients with neuropsychiatric disorders

 

BrainSightAI is building solutions to enable physicians with deep insights across neurobiological and behavioural indicators

Our Snowdrop App enables an extra-clinical view of patient symptoms and activity

Orchid SaaS solution enables early identification of disorder through our proprietary AI models

Aster, Camellia and Rafflesia are SaaS solutions under development for recurrence and surgical planning

Our Existing Research Models 

1.

Schizophrenia v/s Bipolar Disorder

4.

Post surgery recovery prognosis for Glioma

7.

Distinguishing between infections and Glioma

2.

Differential Diagnosis for FTD, MCI and AD

5.

Prognosis of Dementia disorders

8.

Early diagnosis of AD using fMRI

3.

Differential diagnosis of Psychotic disorders

6.

Digital Phenotyping and Neuroimaging correlations

9.

Pre-surgical planning for Glioma using fMRI, sMRI and DTI

Brain Scans

PARTNER WITH US

At BrainSightAI, we are pioneering new tools for understanding the human brain. Our goal is to help patients shorten the path to recovery and good health by taking the leap from informed estimation to data-assured diagnosis and data-predicted prognosis. 

Psychiatrists and Neurologists with a bias for technology driven healthcare solutions are joining hands with us on this mission.Talk to us and find out more about the various ways to partner.